Details of the Drug

General Information of Drug (ID: DMFJB35)

Drug Name

ABO-102

Indication

Disease Entry	ICD 11	Status	REF
Mucopolysaccharidosis	5C56.3	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
N-sulphoglucosamine sulphohydrolase (SGSH)	TTPJ2SH	SPHM_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04088734) Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Abeona Therapeutics.